We are live on
!
Find out more
SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $334M | – | – | – |
|
|
VC
2
Vivo Capital
Palo Alto,
California
| $38.2M | +$38.2M | +5,903,000 | New |
|
|
NAH
3
Neumann Advisory (HK)
Central,
Hong Kong
| $2.04M | – | – | – |
|
4
Renaissance Technologies
New York
| $849K | +$849K | +1,312,520 | New |
|
5
Wells Fargo
San Francisco,
California
| $109K | +$109K | +16,851 | New |
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $106K | +$106K | +16,430 | New |
|
7
Morgan Stanley
New York
| $54K | +$54K | +8,344 | New |
|
8
UBS Group
Zurich,
Switzerland
| $14.3K | +$14.3K | +2,213 | New |
|
|
HI
9
Horizon Investments
Charlotte,
North Carolina
| $336 | +$336 | +52 | New |
|